Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Editorials

Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes?

Department of Medicine, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Sunnybrook Research Institute, Toronto, ON
Department of Medicine, University of Toronto, Toronto, ON, Canada; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Sunnybrook Research Institute, Toronto, ON
Haematologica Early view Jun 26, 2025 https://doi.org/10.3324/haematol.2025.288157

Abstract

Not available.

Figures & Tables

Article Information

Early view : Editorials
 
DOI
https://doi.org/10.3324/haematol.2025.288157
 
Published
2025-06-26
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
120
PDF Downloads
75

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online